Walgreens Boots Alliance Inc (WBA) Stock Price Today
Key Stats
- $10.37BMarket Cap
- -Volume
- Consumer StaplesSector
- $12.9352W High
- $8.2452W Low
- 73 DaysTypical Hold Time
- $38.57BEnterprise Value
- 8.35%Div Yield
- -Trading Activity
Track Walgreens Boots Alliance Inc (WBA) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Walgreens Boots Alliance Inc has traded between a low of $8.24 and a high of $12.93, highlighting its annual price range. Buy and sell Walgreens Boots Alliance Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Walgreens Boots Alliance Inc
Walgreens Boots Alliance is a leading retail pharmacy chain with about 13,000 stores in the U.S. and internationally. Walgreens' core strategy involves brick-and-mortar retail pharmacy locations in high-traffic areas, with nearly 80% of the U.S. population living within 5 miles of a store. Currently, the company has a leading share of the domestic prescription drug market at about 20%. In 2021, the company sold a majority of its Alliance Healthcare wholesale business to AmerisourceBergen for $6.5 billion, doubling down on its core pharmacy efforts and ventures in strategic growth areas in primary care (VillageMD) and digital offerings. The company also has equity stakes in AmerisourceBergen (29%) and Sinopharm Holding Guoda Drugstore (40%).
Most Recent News
Ford recalls over 40,000 vehicles for headlight defect risking driver visibility and safety
Ford is recalling about 41,748 vehicles from model years 2025 to 2027, including Ford Expedition and several Ford Super Duty trucks, due to a headlight defect. The issue involves contaminated LED chips that can cause loss of various exterior lights, ...
Eli Lilly's new obesity drug shows stronger weight loss than Novo Nordisk's, raising market competition.
Eli Lilly announced promising mid-stage trial results for EloraTZP, a new obesity drug that led to up to 23.3% weight loss in overweight or obese type 2 diabetes patients after 48 weeks, outperforming Novo Nordisk's tirzepatide alone. The drug also s...
Autoliv adds two experts to its Research Advisory Board to boost automotive safety innovation.
Autoliv, a global leader in automotive safety systems, has appointed Natalie Draisin and Thomas Manfred Müller to its Research Advisory Board. This board, comprising experts from various fields, guides Autoliv's research on emerging safety challenges...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.